目的 評價調經(jīng)活血膠囊治療原發(fā)性痛經(jīng)的有效性。方法 收集2013年3月—2013年10月在山西醫(yī)科大學第二醫(yī)院和陜西中醫(yī)藥大學附屬醫(yī)院門診就診的原發(fā)性痛經(jīng)患者64例，隨機分為對照組（33例）和試驗組（31例）。對照組患者口服安慰劑膠囊，試驗組患者口服調經(jīng)活血膠囊，4粒/次，3次/d。從月經(jīng)前5 d開始服藥至月經(jīng)第2天，共連續(xù)服藥7 d后停藥。連用3個月經(jīng)周期。比較兩組的VAS疼痛療效和中醫(yī)癥狀療效，比較兩組治療1、2、3個月的VAS評分和中醫(yī)癥狀評分的變化情況。結果 治療后，對照組和治療組VAS疼痛療效的總顯效率分別為12.12%、74.19%，總有效率分別為30.30%、87.10%，兩組總顯效率、總有效率比較差異均有統(tǒng)計學意義（P<0.05）。治療后，對照組和治療組中醫(yī)癥狀療效的總顯效率分別為0、29.03%，總進步率分別為39.39%、74.19%，兩組總顯效率、總進步率比較差異均有統(tǒng)計學意義（P<0.05）。治療2、3個月后，兩組VAS評分、中醫(yī)癥狀積分均顯著降低，同組治療前后比較差異有統(tǒng)計學意義（P<0.05）；治療2、3個月后，治療組VAS評分、中醫(yī)癥狀積分顯著低于對照組，兩組比較差異有統(tǒng)計學意義（P<0.05）。結論 調經(jīng)活血膠囊治療氣滯血瘀型原發(fā)性痛經(jīng)療效顯著，可顯著降低VAS評分和中醫(yī)癥狀積分，具有一定的臨床推廣應用價值。

Objective To evaluate the efficacy of Tiaojing Huoxue Capsules in treatment of qi stagnation and blood stasis primary dysmenorrhea. Methods Patients (64 cases) with qi stagnation and blood stasis primary dysmenorrhea in outpatient service from Second Hospital of Shanxi Medical University and Affiliated Hospital of Shaanxi University of Chinese Medicine from March 2013 to October 2013 were randomly divided into control (33 cases) and treatment (31 cases) groups. Patients in the control group were po administered with Placebo Capsules, and patients in the control group were po administered with Tiaojing Huoxue Capsules, 4 grains/time, three times daily. They started from 5 d before menstruation until the second day of menstruation, and they were treated for 7 d. Patients in two groups were treated for 3 menstrual cycles. After treatment, the VAS efficacies and TCM syndrome efficacies was evaluated, and the changes of VAS score and TCM syndrome score in two groups in two groups before and after treatment were compared. Results After treatment, the total efficiency of VAS pain curative effect in the control and treatment groups were 12.12%, 74.19%, and the clinical efficacy were 30.30%, 87.10%, and there were differences between two groups (P < 0.05). After treatment, the total efficiency of TCM syndrome efficacies in the control and treatment groups were 0, 29.03%, and the total progress rate were 39.39%, 74.19%, and there were differences between two groups (P < 0.05). After 2 and 3 months of treatment, VAS score and TCM symptom score in two groups were significantly decreased, and there were differences in the same group (P < 0.05). After treatment, VAS score and TCM symptom score in the treatment group were lower than those in the control group, and there were differences between two groups (P < 0.05). Conclusion Tiaojing Huoxue Capsules has significant clinical effect in treatment of qi stagnation and blood stasis primary dysmenorrhea, and can significantly reduce the VAS score and TCM symptom score, which has a certain clinical application value.